Macquarie Group Ltd. grew its position in UnitedHealth Group Incorporated (NYSE:UNH) by 4.4% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 347,791 shares of the healthcare conglomerate’s stock after acquiring an additional 14,568 shares during the period. Macquarie Group Ltd.’s holdings in UnitedHealth Group were worth $64,488,000 at the end of the most recent reporting period.

A number of other hedge funds also recently bought and sold shares of the stock. Sii Investments Inc. WI raised its position in UnitedHealth Group by 4.4% in the 2nd quarter. Sii Investments Inc. WI now owns 8,976 shares of the healthcare conglomerate’s stock worth $1,665,000 after purchasing an additional 379 shares during the last quarter. Flinton Capital Management LLC raised its position in UnitedHealth Group by 0.5% in the 2nd quarter. Flinton Capital Management LLC now owns 204,512 shares of the healthcare conglomerate’s stock worth $37,921,000 after purchasing an additional 1,092 shares during the last quarter. Fred Alger Management Inc. raised its position in UnitedHealth Group by 4.8% in the 2nd quarter. Fred Alger Management Inc. now owns 2,438,363 shares of the healthcare conglomerate’s stock worth $452,121,000 after purchasing an additional 112,707 shares during the last quarter. Logan Capital Management Inc. raised its position in UnitedHealth Group by 22.0% in the 2nd quarter. Logan Capital Management Inc. now owns 3,307 shares of the healthcare conglomerate’s stock worth $613,000 after purchasing an additional 596 shares during the last quarter. Finally, Capital International Investors raised its position in UnitedHealth Group by 25.7% in the 2nd quarter. Capital International Investors now owns 827,700 shares of the healthcare conglomerate’s stock worth $153,472,000 after purchasing an additional 169,100 shares during the last quarter. Hedge funds and other institutional investors own 86.20% of the company’s stock.

Several research analysts recently weighed in on the stock. Jefferies Group restated a “buy” rating and issued a $248.00 price objective on shares of UnitedHealth Group in a research report on Friday, December 1st. Leerink Swann reaffirmed an “outperform” rating on shares of UnitedHealth Group in a report on Friday, December 1st. Sanford C. Bernstein lifted their target price on shares of UnitedHealth Group from $219.00 to $246.00 and gave the stock an “outperform” rating in a report on Friday, December 1st. ValuEngine lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday. Finally, Raymond James Financial reaffirmed a “buy” rating on shares of UnitedHealth Group in a report on Wednesday. Three research analysts have rated the stock with a hold rating and twenty-four have assigned a buy rating to the company’s stock. The stock has an average rating of “Buy” and a consensus price target of $224.56.

Shares of UnitedHealth Group Incorporated (NYSE UNH) traded up $3.76 during mid-day trading on Friday, hitting $223.91. 2,233,073 shares of the stock traded hands, compared to its average volume of 2,655,638. UnitedHealth Group Incorporated has a one year low of $156.09 and a one year high of $231.77. The firm has a market cap of $216,984.02, a price-to-earnings ratio of 23.32, a price-to-earnings-growth ratio of 1.66 and a beta of 0.66. The company has a quick ratio of 0.70, a current ratio of 0.70 and a debt-to-equity ratio of 0.52.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, October 17th. The healthcare conglomerate reported $2.66 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.57 by $0.09. UnitedHealth Group had a net margin of 4.50% and a return on equity of 21.52%. The company had revenue of $50.32 billion during the quarter, compared to analyst estimates of $50.38 billion. During the same quarter in the previous year, the business earned $2.17 EPS. The firm’s revenue was up 8.7% on a year-over-year basis. sell-side analysts predict that UnitedHealth Group Incorporated will post 9.99 earnings per share for the current year.

The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 12th. Stockholders of record on Friday, December 1st will be issued a $0.75 dividend. This represents a $3.00 annualized dividend and a dividend yield of 1.34%. The ex-dividend date of this dividend is Thursday, November 30th. UnitedHealth Group’s dividend payout ratio (DPR) is 33.26%.

In related news, Director Gail R. Wilensky sold 5,600 shares of the company’s stock in a transaction on Wednesday, November 29th. The shares were sold at an average price of $223.31, for a total value of $1,250,536.00. Following the completion of the transaction, the director now directly owns 61,137 shares of the company’s stock, valued at approximately $13,652,503.47. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, insider Larry C. Renfro sold 50,574 shares of the company’s stock in a transaction on Friday, September 15th. The stock was sold at an average price of $198.11, for a total transaction of $10,019,215.14. Following the completion of the transaction, the insider now directly owns 195,625 shares of the company’s stock, valued at $38,755,268.75. The disclosure for this sale can be found here. Insiders sold a total of 62,606 shares of company stock valued at $12,677,525 in the last three months. 0.89% of the stock is owned by company insiders.

WARNING: This piece was first published by Watch List News and is the property of of Watch List News. If you are accessing this piece on another site, it was copied illegally and republished in violation of US and international trademark & copyright laws. The correct version of this piece can be accessed at https://www.watchlistnews.com/unitedhealth-group-incorporated-unh-shares-bought-by-macquarie-group-ltd/1755754.html.

UnitedHealth Group Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with Analyst Ratings Network's FREE daily email newsletter.